Sale!

Immunophenotyping by Flow Cytometry CD33 Test Cost

Original price was: 530 د.إ.Current price is: 480 د.إ.

-9%

Immunophenotyping by Flow Cytometry CD33 Test is a specialized diagnostic procedure performed to identify and analyze cells expressing the CD33 antigen, commonly found on the surface of myeloid cells. This test is crucial in the diagnosis and management of various hematological disorders, including certain types of leukemia, where CD33 expression can be a significant marker for disease identification and progression. The process involves using flow cytometry technology to quantify and categorize cells based on their physical and chemical characteristics, providing detailed insights into the cellular composition of a sample.

At DNA Labs UAE, the Immunophenotyping by Flow Cytometry CD33 Test is available for a cost of 480 AED. The facility employs cutting-edge technology and expertise to ensure accurate and reliable results, aiding in the effective diagnosis and treatment planning for patients with myeloid-related hematological conditions. This test is a valuable tool in the clinical setting, offering critical information that can influence treatment decisions and patient outcomes.

Description

IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD33 Test

Test Name: IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD33 Test

Components: CD33 Test

Price: 480.0 AED

Sample Condition: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube AND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Specify time, date, and clinical details on the test request form.

Report Delivery: Sample Daily by 9 am; Report Same day

Method: Flow Cytometry

Test Type: Cancer

Doctor: Oncologist, Hematologist

Test Department: FLOW CYTOMETRY

Pre Test Information: Give brief clinical history.

Test Details:

The CD33 test is a flow cytometry-based immunophenotyping assay that is used to detect the presence and quantity of CD33 antigen on the surface of cells. CD33 is a transmembrane glycoprotein that is primarily expressed on myeloid cells, including granulocytes, monocytes, and dendritic cells. It is also found on the surface of leukemic blasts in acute myeloid leukemia (AML).

The CD33 test is commonly used in the diagnosis and monitoring of AML. By analyzing the expression of CD33 on leukemic blasts, clinicians can determine the subtype of AML and guide treatment decisions. In addition, the CD33 test can also be used to monitor minimal residual disease (MRD) after treatment to assess treatment response and disease progression.

The test involves the labeling of cells with fluorescently-labeled antibodies specific for CD33. The labeled cells are then analyzed using flow cytometry, which measures the fluorescence intensity of each cell. By comparing the fluorescence intensity of the labeled cells to a control sample, the percentage of cells expressing CD33 can be determined.

Overall, the CD33 test is a valuable tool in the diagnosis and monitoring of AML, providing important information about the presence and quantity of CD33 antigen on leukemic cells.

Test Name	IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD33 Test
Components
Price	480.0 AED
Sample Condition	3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tubeAND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on test request form.
Report Delivery	Sample Daily by 9 am;Report Same day
Method	Flow Cytometry
Test type	Cancer
Doctor	Oncologist, Hematologist
Test Department:	FLOW CYTOMETRY
Pre Test Information	Give brief clinical history.
Test Details	The CD33 test is a flow cytometry-based immunophenotyping assay that is used to detect the presence and quantity of CD33 antigen on the surface of cells. CD33 is a transmembrane glycoprotein that is primarily expressed on myeloid cells, including granulocytes, monocytes, and dendritic cells. It is also found on the surface of leukemic blasts in acute myeloid leukemia (AML). The CD33 test is commonly used in the diagnosis and monitoring of AML. By analyzing the expression of CD33 on leukemic blasts, clinicians can determine the subtype of AML and guide treatment decisions. In addition, the CD33 test can also be used to monitor minimal residual disease (MRD) after treatment to assess treatment response and disease progression. The test involves the labeling of cells with fluorescently-labeled antibodies specific for CD33. The labeled cells are then analyzed using flow cytometry, which measures the fluorescence intensity of each cell. By comparing the fluorescence intensity of the labeled cells to a control sample, the percentage of cells expressing CD33 can be determined. Overall, the CD33 test is a valuable tool in the diagnosis and monitoring of AML, providing important information about the presence and quantity of CD33 antigen on leukemic cells.